Via its ECM-modulating capacity, TGFβ contributes to the phenomenon of tumor T cell exclusion, which means that the accessibility of the tumor tissue for invading immune cells can be blocked by the formation of a collagen-rich ECM barrier [138]. This evidence concerns the gene TGFB1 and neoplasm.